Marsh & McLennan Companies Inc (MRSH)

Marsh & McLennan Companies, Inc. is a New York-based professional services group listed on the NYSE as common stock. Through its Risk and Insurance Services and Consulting segments, the company provides clients worldwide with advisory and solutions focused on risk, strategy, and people. Its risk-related businesses include risk management, insurance broking, insurance program management, risk consulting, analytical modeling, alternative risk financing, reinsurance broking, strategic advisory, actuarial services, and analytics. The consulting segment offers health, wealth and career guidance, along with specialized management, strategic, economic, and brand consulting services. Founded in 1871, Marsh & McLennan serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-MRSH
$202.91
15.9% Upside
Fair
$207.10
18.3% Upside
Undervalued
Fair
October 1, 2026
November 13, 2026
2.3%
October 15, 2026
20.9x
5.5x
3.0x
83.517 B
104.2 B
21.1%
99.8%
4.2
44.0%
119.8%
Valuation • Fair Value

Marsh & McLennan Companies Inc (NYSE-MRSH) Fair Value by Valuation Model

Review the available estimates for Marsh & McLennan Companies Inc (NYSE-MRSH), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$202.91

Estimated upside of 15.9% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$216.60

Discounted cash flow valuation reference.

Ben Graham Formula Value

$92.54

Classic Ben Graham valuation formula reference.

DDM Fair Value

$250.75

Dividend discount model valuation reference.

EPV Fair Value

$103.66

Earnings power value estimate.

Comps Fair Value

$189.80

Comparable-company valuation reference.

Analyst Price Target

$207.10

Analysts imply upside of 18.3%.

How to read these valuation models

Use the 8 available valuation references for Marsh & McLennan Companies Inc (NYSE-MRSH) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Marsh & McLennan Companies Inc (NYSE-MRSH)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

27.947 B

Current operating scale indicator.

Revenue Forecast

28.57 B

Forward revenue estimate.

EBITDA

7.758 B

Current operating profitability reference.

EBITDA Forecast

8.163 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Marsh & McLennan Companies Inc (NYSE-MRSH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Marsh & McLennan Companies Inc (NYSE-MRSH)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Altman Z-Score

4.2

Relatively strong balance-sheet zone.

FCF / Net Income

119.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Marsh & McLennan Companies Inc (NYSE-MRSH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Marsh & McLennan Companies Inc (NYSE-MRSH)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 15, 2026

Days to Earnings

27

Dividend Payment Date

November 13, 2026

Ex-Dividend Date

October 1, 2026

Dividend Yield

2.3%

Current income yield reference.

Payout Ratio

44.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Marsh & McLennan Companies Inc (NYSE-MRSH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Marsh & McLennan Companies Inc (NYSE-MRSH) Stock Forecast & Technical Outlook

Review Marsh & McLennan Companies Inc (NYSE-MRSH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Marsh & McLennan Companies Inc (NYSE-MRSH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Marsh & McLennan Companies Inc (NYSE-MRSH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Marsh & McLennan Companies Inc (NYSE-MRSH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Marsh & McLennan Companies Inc (NYSE-MRSH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Marsh & McLennan Companies Inc (NYSE-MRSH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Marsh & McLennan Companies Inc (NYSE-MRSH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Marsh & McLennan Companies Inc (NYSE-MRSH) has a Hold consensus, with 5 buy, 15 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 15
Sell 0
FAQ Fast Investor Answers

Marsh & McLennan Companies Inc (NYSE-MRSH) Stock FAQ

Data-supported answers about Marsh & McLennan Companies Inc (NYSE-MRSH), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$202.91
Estimated upside 15.9%
Valuation Rating
Undervalued
Estimated upside of 15.9%
Analyst Target
$207.10
Implied upside 18.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Marsh & McLennan Companies Inc (NYSE-MRSH) is $202.91. This implies an estimated upside of 15.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 15.9% versus the current market price.

The available analyst price target for Marsh & McLennan Companies Inc (NYSE-MRSH) is $207.10. The analyst target implies estimated upside of 18.3%.

The current financial health read for Marsh & McLennan Companies Inc (NYSE-MRSH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Marsh & McLennan Companies Inc (NYSE-MRSH) is October 15, 2026.

Based on the current data, dividend yield is 2.3%, ex-dividend date is October 1, 2026, payment date is November 13, 2026.

The current P/E ratio listed for Marsh & McLennan Companies Inc (NYSE-MRSH) is 20.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Marsh & McLennan Companies Inc is 83.517 B.

The current enterprise value listed for Marsh & McLennan Companies Inc is 104.2 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Marsh & McLennan Companies Inc is NYSE-MRSH, and the stock is listed on NYSE.

Marsh & McLennan Companies Inc (NYSE-MRSH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Marsh & McLennan Companies Inc is 21.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Marsh & McLennan Companies Inc is 99.8%. Free float helps investors understand how much of the share base is available for public trading.